Insurance company’s claim of medical concealment rejected; family awarded full coverage plus interest
NEW DELHI — In a landmark verdict that strengthens consumer protection in insurance claims, the Delhi District Consumer Court has ordered Aditya Birla Sun Life Insurance Company Limited to pay ₹3 crore to the family of Yogesh Gupta, who died of COVID-19 in May 2021. The company had initially rejected the claim, alleging that Gupta had concealed pre-existing medical conditions when purchasing the policy.
The bench, comprising Chairperson Poonam Chaudhary and Member Shekhar Chandra, delivered its decision on January 6, 2026, completely dismantling the insurance company’s defence and awarding the family additional compensation for litigation costs and interest.
The Full Award
Beyond the ₹3 crore insurance amount, the court ordered:
- 6% annual interest on ₹3 crore from the date of the original claim in May 2021
- 9% annual interest if payment is not made within four weeks of the verdict
- ₹25,000 in litigation costs to cover legal expenses
The escalating interest clause effectively pressurizes the company to settle promptly, making delay increasingly costly.
The Case That Spanned Five Years
The dispute began in March 2020 when Yogesh Gupta purchased a ₹3 crore life insurance policy. He paid ₹30 lakh as the first instalment, and the insurance company conducted comprehensive medical tests as part of the underwriting process. These tests found no serious health concerns—his HbA1c level was measured at 5.6%, which falls within the normal range and showed no signs of diabetes.
The policy was issued in April 2020, just as India was grappling with the early stages of the COVID-19 pandemic. The family could not have anticipated the tragedy that would follow.
In April 2021, Yogesh contracted COVID-19 and was admitted to Apollo Hospital in New Delhi with critical symptoms. His condition deteriorated rapidly, and he passed away on May 8, 2021. The hospital’s medical report cited severe COVID pneumonia as the primary cause of death, while also noting the presence of underlying conditions including diabetes and hypothyroidism.
The Insurance Company’s Defence Crumbles
When Yogesh’s wife, Kavita Gupta, and their two children—daughter Richa and son Varun—filed an insurance claim in May 2021, the company rejected it outright. Aditya Birla Sun Life argued that Yogesh had concealed his diabetes when he applied for the policy, citing this alleged concealment as grounds to deny the ₹3 crore claim.
The family refused to accept this rejection and filed a complaint with the Delhi Consumer Court in February 2022, beginning a four-year legal battle.
The Court’s Reasoning
The bench systematically dismantled each element of the insurance company’s case, basing its decision on three critical findings:
Medical Evidence Was Unambiguous: The court noted that the insurance company itself had conducted medical tests at the time of policy issuance, and these tests showed no serious health problems. With an HbA1c level of 5.6%, Yogesh showed no signs of diabetes—the very condition the company claimed he had concealed. The company’s own medical assessment contradicted its later allegations.
COVID-19, Not Pre-existing Conditions, Caused Death: While the hospital records mentioned diabetes and hypothyroidism as co-conditions, the primary cause of death was explicitly stated as severe COVID pneumonia. The court rejected the company’s attempt to attribute the death to pre-existing conditions that were not the direct cause.
Precedent Against Claim Denial in COVID Cases: The bench cited a Supreme Court judgment establishing that withholding insurance claims for deaths due to COVID-19 is unjust and contrary to public policy. The court also referenced multiple National Consumer Commission judgments in similar cases, establishing a pattern of judicial precedent against such rejections.
Broader Implications
This verdict carries significant implications for insurance practices during and after the pandemic. It establishes that insurance companies cannot rely on vague allegations of medical concealment, particularly when their own underwriting procedures failed to identify any health concerns. The court has effectively held companies accountable for their own due diligence processes.
The decision also reinforces that COVID-19 claims cannot be arbitrarily rejected based on the presence of co-morbidities, as long as the pandemic illness itself is the primary cause of death—a crucial protection for millions of families who lost loved ones during the outbreak.
The Family’s Relief
After nearly five years of legal proceedings, Yogesh’s family—his widow Kavita and their two children—will now receive the full insurance coverage their husband and father had secured for their financial protection. The court’s award of ₹3 crore, plus interest calculated from 2021, represents a significant financial lifeline for the family during their period of grievance.
The case underscores the importance of consumers persisting in challenging unfair insurance denials and the role of consumer courts in protecting the interests of ordinary families against large corporations.
Leave a Reply